SY40-04 - Committee for Opportunity and Reaching Excellence (CORE) Health Disparity Symposium: Health Disparities in Endocrine Neoplasia: Access and Innovation
Leon Goldman, MD Distinguished Professor of Surgery and Chair, Dept of Surgery UCSF San Francisco, CA, United States
Disclosure(s):
Julie Ann Sosa, MD: .NovoNordisk: Member, Data Monitoring Committee of the Medullary Thyroid Cancer Consortium Registry (); ASTRA ZENECA: Member, Data Monitoring Committee of the Medullary Thyroid Cancer Consortium Registry (); Eli Lilly & Company: Member, Data Monitoring Committee of the Medullary Thyroid Cancer Consortium Registry (); Exelixis: Institutional research funding ()
Description: The Committee for Opportunity and Reaching Excellence (CORE) HD Symposium will examine health disparities in endocrine neoplasia across patient populations and health care systems. Experts from multiple disciplines will discuss inequities in access to surgical and oncologic care, clinical trial participation, and challenges encountered in international practice settings. The session will also address survivorship care and disparities in the integration of emerging technologies and advanced therapies. Through multidisciplinary dialogue, this symposium aims to identify actionable approaches that promote innovation, access, and excellence in endocrine oncology.
